Official Government Website

Idaho Prescription Drug Monitoring Program Data Dashboard

PDMP Overview

In 1997, the Idaho Legislature passed §37-2726, mandating the Idaho Board of Pharmacy (IDBOP) develop the Prescription Tracking Program. The purpose of this program is to assist in the prevention of prescription drug abuse, misuse, overdose and death by providing healthcare providers and pharmacists a tool to help provide better care when managing their patient’s controlled substance prescriptions. Per Idaho code 37-2726, this data is made available to specific authorized individuals for specific reasons. IDAPA directs reporting to the PDMP for all Idaho licensed drug outlets that dispense controlled substances in or into Idaho and prescribers that dispense controlled substances to humans. Certain drugs are considered controlled substances by the DEA and are categorized into schedules based upon medically accepted use and the potential for abuse and dependence. The PDMP Data Dashboard presents state and county level data on controlled substance prescribing and dispensations. The data source for the dashboard is from the Idaho PDMP which collects all controlled substance prescriptions, schedules II, III, IV and V.

PDMP Fast Facts

Total Controlled Substance Prescriptions in Idaho 2021*
Total Opioid Prescriptions in Idaho 2021
Total Buprenorphine Prescriptions in Idaho 2021
Total Stimulant Prescriptions in Idaho 2021

*Locations of prescriptions are based on patient location.

Drug Overdose Prevention Program

Idaho Opioid Data Dashboard and Data
Dashboard and Data are available as a result of ongoing collaboration between the Idaho Division of Public Health, Idaho Board of Pharmacy, Centers for Disease Control and Prevention, and Bureau of Justice Assistance (BJA).

Active PMPi Connections

PMP InterConnect, is a national network of Prescription Drug Monitoring Programs. It is a secure data-sharing hub that enables the sharing of PDMP data across state lines, providing prescribers and pharmacists with a more complete patient history. This capability allows physicians and pharmacists to more easily identify patients who may be obtaining prescription medications for any purpose other than the treatment of an existing medical condition, including for purposes of abuse, misuse or diversion, especially if those patients are crossing state lines to obtain drugs. Currently the Idaho PDMP data shares with 33 states, the territory of Puerto Rico and the Military Health System.
To learn more about PMPInterconnect and view additional interactive PMPInterconnect maps go to:

Idaho Opioid Prescriptions

Opioids include full opioid agonist, partial opioid agonists, and combination opioid agonist/antagonist pharmacological classes. This includes buprenorphine/naloxone combinations as well as codeine anti-tussives by prescription.

Hover over each item for more information. Use arrows to navigate each year where applicable.
Idaho Population data provided by the Idaho Department of Health and Welfare. Locations of prescriptions are based on patient location.

Unsolicited Reports

The Board of Pharmacy is authorized to provide unsolicited information to practitioners and pharmacists by Idaho Code 37-2730A(2)…The board may release unsolicited information to pharmacists and practitioners when the release of information may be of assistance in preventing or avoiding inappropriate use of controlled substances. Each calendar month board staff identifies patients that have obtained controlled substances from four or more practitioners and 2 or more pharmacies. Each practitioner and pharmacy that has serviced these patients are notified using the Aware PDMP program. The board makes no judgements regarding these patients or their care, the notice is sent only to ensure each practitioner is aware of the controlled substances obtained by the patient. It is up to the practitioner to decide if further action is appropriate. The number of patients has declined over the last five years. One reason is better analysis of the data as long-term care providers and cancer treatment providers are identified. We believe the other reason is due to the Unsolicited Reports program bringing awareness to providers.

PDMP Searches

ver: 3.5.1 | last updated: